Is Abcam a good dividend stock?

Abcam (OTCMKTS:ABCZY) pays an annual dividend of $0.07 per share and currently has a dividend yield of 0.36%. Read our dividend analysis for ABCZY .

How do I buy shares of Abcam?

Shares of ABCZY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Does Abcam have any subsidiaries?

The following companies are subsidiares of Abcam: Abcam (US) Ltd., Abcam Trading (Shanghai) Co. Ltd., Abcam US Group Holdings Inc., and Epitomics Inc. Read More

OTCMKTS:ABCZY

Abcam (ABCZY) Stock Price, News & Analysis

→ Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad)

Free ABCZY Stock Alerts

Compare

Today's Range: N/A
50-Day Range: $19.40
▼
$19.40
52-Week Range: N/A

Volume: 5,400 shs
Average Volume: 4,712 shs
Market Capitalization: $3.98 billion

P/E Ratio: N/A
Dividend Yield: 0.36%
Price Target: N/A

Stock Analysis

Get Abcam alerts:

Ad Darwin

Your Next Portfolio Star: Revealing 2024's Top Stock Pick

We're thrilled to offer you an exclusive look at the #1 Buy & Hold Stock of 2024. This isn't just any report. It's the culmination of rigorous analysis, expert insights, and cutting-edge financial strategies, distilled into a compelling narrative that charts the course of what we believe to be the year's most promising investment. (**By clicking the link you are subscribing to The Wealth Creation Investing Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)

Click here to download your report

About Abcam Stock (OTCMKTS:ABCZY)

Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Germany, the United Kingdom, and internationally. The company offers various research products, including primary and secondary antibodies; ELISA and matched antibody pairs; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex assays. Its research products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. The company also offers diagnostic and therapeutic solutions. The company also sells its products online. Abcam plc has partnership with Cancer Research UK for the development and commercialization of novel custom antibodies to support the acceleration of cancer research. Abcam plc was founded in 1998 and is headquartered in Cambridge, the United Kingdom.

Ad DTI

With the “Bitcoin Loophole” you can supercharge the gains by 10x or more

Thanks to this newly discovered Bitcoin Loophole, you can now trade Bitcoin in any regular brokerage account… And not only that… you can use it to supercharge the gains of Bitcoin by 10x or more! You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history. That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords…

ABCZY Stock News Headlines

March 18, 2024 | msn.com

Long-standing Danaher executive Markus Lusser becomes new president of Abcam

March 18, 2024 | finance.yahoo.com

Abcam appoints Markus Lusser as new President

April 19, 2024 | DTI (Ad)

Special FREE offer on stock hotsheets

These sheets tell you the exact day you should consider buying a stock… And the exact day you should consider selling it… All based on TEN YEARS of historic data and trends. For example, like January 6th through the 12th with Apple… It’s gone up every single year for the last decade. Or like May 26th through June 11th with LULU… Again - it’s gone up every single year for the last decade. Then there’s July 1st through the 21st with Walmart… What happened to WMT?

November 7, 2023 | msn.com

Danaher deal for Abcam approved by 89 per cent of shareholders

November 6, 2023 | uk.news.yahoo.com

Abcam shareholders approve $5.7 billion Danaher deal

November 1, 2023 | thetimes.co.uk

Abcam founder ends fight to block takeover

October 23, 2023 | finance.yahoo.com

Leading Independent Proxy Advisor Glass Lewis Joins ISS in Recommending Shareholders Vote "FOR" Danaher Corporation’s Proposed Acquisition of Abcam

October 21, 2023 | msn.com

Efforts to stop takeover of biotech firm Abcam dealt a blow

April 19, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

October 19, 2023 | msn.com

Top Abcam Investor HBK Voices Support for $5.7 Billion Sale

October 17, 2023 | stockhouse.com

Leading Proxy Advisor, ISS, Recommends Shareholders Vote "FOR" Danaher Corporation's Proposed Acquisition of Abcam

October 16, 2023 | proactiveinvestors.com

Exlusive: Why Abcam founder believes Danaher's acquisition offer falls short

October 16, 2023 | msn.com

HBK Capital Becomes Biggest Abcam Investor, Set to Support Sale

October 14, 2023 | msn.com

Abcam founder's concern over exodus of British life science companies

October 14, 2023 | msn.com

Abcam founder speaks out against growing exodus of British life science companies

October 12, 2023 | finance.yahoo.com

Independent Directors of Abcam Highlight Compelling Reasons for Shareholders to Support Proposed Sale to Danaher

October 5, 2023 | msn.com

Abcam received multiple bids in sales process, contacted over 30 parties

October 5, 2023 | ft.com

Life sciences group Abcam rejects founder’s accusations over $5.7bn deal with Danaher

October 4, 2023 | msn.com

Abcam challenger hits out as process to set EGM date goes on

September 28, 2023 | msn.com

Abcam founder slams £4.5bn sale to US conglomerate Danaher

September 28, 2023 | ca.news.yahoo.com

UK Life Sciences Firm Abcam’s Founder Fights $5.7 Billion Bid

September 15, 2023 | msn.com

UPDATE 3-Abcam founder seeks to block $5.7 billion Danaher deal

September 15, 2023 | msn.com

Signal: Danaher’s $5.7bn acquisition of Abcam faces stand-off with founder

September 14, 2023 | finance.yahoo.com

Abcam plc Statement on Dr. Jonathan Milner’s Announcement

September 14, 2023 | thetimes.co.uk

Abcam founder Jonathan Milner renews clear-out bid

September 14, 2023 | investing.com

Abcam plc founder to vote against proposed $5.7B Danaher acquisition, believes offer undervalues the company

September 14, 2023 | finance.yahoo.com

Dr. Jonathan Milner opposes Danaher's acquisition of Abcam and calls for EGM to replace Board

See More Headlines

Receive ABCZY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Industrial Inorganic Chemicals
Sub-Industry: N/A
Current Symbol: OTCMKTS:ABCZY
Previous Symbol: NASDAQ:ABCZY
CUSIP: N/A
CIK: N/A
Web: www.abcam.com
Phone: 44 1223 696 000
Fax: N/A
Employees: 1,492
Year Founded: 1998

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $336.37 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 205,080,000
Free Float: N/A
Market Cap: $3.98 billion
Optionable: Not Optionable
Beta: 1.29

Social Links

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Mr. Alan Thomas Hirzel BS (Age 52)
MS, MBA, CEO & Exec. Director
Mr. Michael Shaun Baldock (Age 54)
CFO & Director
Dr. Jonathan Simon Milner (Age 55)
Co-Founder & Non-Exec. Deputy Chairman
Mr. Mark Dermody
Interim CIO
James Staveley
VP of Investor Relations

Key Competitors

View All Competitors

ABCZY Stock Analysis - Frequently Asked Questions

Is Abcam a good dividend stock?: Abcam (OTCMKTS:ABCZY) pays an annual dividend of $0.07 per share and currently has a dividend yield of 0.36%.
Read our dividend analysis for ABCZY.
How do I buy shares of Abcam?: Shares of ABCZY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
Does Abcam have any subsidiaries?: The following companies are subsidiares of Abcam: Abcam (US) Ltd., Abcam Trading (Shanghai) Co. Ltd., Abcam US Group Holdings Inc., and Epitomics Inc.
Read More

This page (OTCMKTS:ABCZY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial